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Xanthorrhizol is an active component isolated from Curcuma
xanthorrhiza Roxb. (Zingiberaceae) that is traditionally used in
Indonesia for medicinal purposes. In the present study, we found
that the topical application of xanthorrhizol before 12-O-tetrade-
canoylphorbol-13-acetate (TPA) treatment significantly inhibits
TPA-induced mouse ear edema and TPA-induced tumor promo-
tion in 7,12-dimethylbenz[a]anthracene (DMBA)-initiated ICR
mouse skin. The topical application of xanthorrhizol following
the induction of papillomas with TPA-induced hyperplasia and
dysplasia also reduced tumor multiplicity and incidence in
DMBA-initiated mouse skin. To further elucidate the molecular
mechanisms underlying the antitumor-promoting activity of xan-
thorrhizol, its effect on the TPA-induced expression of ornithine
decarboxylase (ODC), cyclooxygenase-2 (COX-2) and inducible
nitric oxide synthase (iNOS) and the upstream signaling mole-
cules controlling these proteins were explored in mouse skin.
The pre-treatment with xanthorrhizol inhibited the expression
of ODC, iNOS and COX-2 proteins and nuclear factor-kB (NF-
kB) activation in both mouse skin with TPA-induced acute in-
flammation and DMBA-initiated mouse skin promoted by TPA
for 19 weeks. When mouse skin was treated after TPA-induced
production of papillomas, xanthorrhizol remarkably suppressed
the expression of ODC, iNOS and COX-2 and inhibited the acti-
vation of NF-kB. Furthermore, western blot analysis showed that
xanthorrhizol suppressed the activation of extracellular signal-
regulated protein kinase, p38, c-Jun-N-terminal kinase and Akt
in mice after topical application for 6 weeks following the induc-
tion of papillomas. Taken together, the present study demon-
strates that xanthorrhizol not only delays or inhibits tumor
formation, but also reverses the carcinogenic process at pre-
malignant stages by reducing the protein levels of ODC, iNOS
and COX-2 regulated by the NF-kB, mitogen-activated protein
kinases and/or Akt.
Introduction
Cancer chemoprevention is defined as the administration of agents to
prevent the induction of or to inhibit or delay the progression of
cancer (1). A chemopreventive agent may also inhibit or reverse car-
cinogenesis at a pre-malignant stage (2). All stages of carcinogenesis,
termed initiation, promotion and progression, can be targeted for
chemopreventive intervention (3). Chemoprevention is recognized
as an important approach to control malignancy and recent studies
have focused on the search for desirable chemopreventive agents.
Plant-derived phytochemicals are a promising and important group
of potential cancer chemopreventive agents because of their low tox-
icity and apparent benefit in other chronic diseases (4). Particularly,
phytochemicals with antioxidative and anti-inflammatory activities
have demonstrated potent chemopreventive and anticancer activity
in multi-stage carcinogenesis (5,6).
Previous reports suggest that 12-O-tetradecanoylphorbol-13-acetate
(TPA) promotes 7,12-dimethylbenz[a]anthracene (DMBA)-initiated
mouse skin carcinogenesis, which is closely related to the inflammatory
responses. These responses include the development of edema, hyper-
plasia, induction of pro-inflammatory cytokine interleukin-1a, en-
hanced release of reactive oxygen species, induction of epidermal
ornithine decarboxylase (ODC) and over-expression of cyclooxyge-
nase-2 (COX-2) and inducible nitric oxide synthase (iNOS) proteins
(7,8). In addition, increased expression of COX-2 and/or iNOS was
observed in many different types of tumors and transformed cells
(9,10). The COX-2 protein catalyzes the biosynthesis of prostaglandins
from arachidonic acid (11). Unlike the constitutively expressed COX-1
important for maintaining normal physiological functions, COX-2 is
undetectable in most normal tissues and is induced transiently by pro-
inflammatory cytokines, growth factors, oncogenes and tumor pro-
moters (12). Over-expression of COX-2 inhibits apoptosis and in-
creases the proliferation, invasiveness and metastasis of malignant
cells (13,14). Another inducible enzyme, iNOS causes the overproduc-
tion of nitric oxide during inflammation and tumor development
(15,16). Besides its ability to act as an initiator of carcinogenesis, nitric
oxide is also involved in the promotional stage of tumorigenesis or
neoplastic transformation (17) and in tumor progression by regulating
angiogenesis (18). Therefore, suppressing the induction and activity
of COX-2 and/or iNOS is a new paradigm for preventing carcinogen-
esis in several organs. In fact, the molecular mechanism underlying
the chemopreventive activities of some compounds derived from edible
or traditional medicinal plants is to inhibit COX-2 and iNOS expression
(19,20).
Xanthorrhizol is a sesquiterpenoid isolated from the rhizomes of
Curcuma xanthorrhiza Roxb. (Zingiberaceae) which is known as te-
mu lawak or Javanese tumeric, and is structurally related with curcu-
min from Curcuma longa Linn. (21). It is traditionally used in
Indonesia for dietary and medicinal purpose as cholagogues, aromatic
stomachics, analgesics and as a rheumatic remedy (22). Although the
anti-inflammatory (23) and antitumor activity (24) of the extract of
C.xanthorrhiza has been reported, little attention has been paid to the
activity of xanthorrhizol, one of its principle active ingredients. Re-
cently, our group reported that xanthorrhizol suppressed COX-2 and
iNOS activity in lipopolysaccharide-treated mouse macrophages (25)
and inhibited the formation of tumor nodules in a spontaneous mouse
lung metastasis model (26).
In the present study to assess the cancer chemopreventive activity of
xanthorrhizol, we examined the anti-inflammatory and antitumor-pro-
moting activity of xanthorrhizol in TPA-induced acute inflammation
and in a multi-stage mouse skin carcinogenesis model, an ideal system
Abbreviations: BCA, bicinchoninic acid; COX-2, cyclooxygenase-2; DMBA,
7,12-dimethylbenz[a]anthracene; DMSO, dimethylsulfoxide; EI, electron ion-
ization; EDTA, ethylenediaminetetraacetic acid; ERK, extracellular signal-
regulated protein kinase; iNOS, inducible nitric oxide synthase; JNK, c-jun-
N-terminal kinase; MEK, MAPK kinase; MAPK, mitogen-activated protein
kinase; NMR, nuclear magnetic resonance; NF-jB, nuclear factor-jB; ODC,
ornithine decarboxylase; PBST, phosphate-buffered saline containing 0.1%
Tween 20; PTEN, phosphatase and tensin homologue deleted on chromosome
10; TPA, 12-O-tetradecanoylphorbol-13-acetate.
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to study a number of biochemical alterations in the different stages of
chemical carcinogenesis (27). To further elucidate the molecular
mechanisms underlying the antitumor activity of xanthorrhizol, its
effect on the TPA-induced activation of ODC, COX-2 and iNOS
and the upstream signaling molecules controlling these proteins were
also explored in mouse skin with inflammation, and at the different
promotional stages during multi-stage skin carcinogenesis.
Materials and methods
Materials
The DMBA, TPA and dimethylsulfoxide (DMSO) were purchased from Sigma
Chemical Co. (St Louis, MO). All other chemicals and solvents used were
commercial products of analytical grade. Rabbit polyclonal COX-2 antibody
was purchased from Cayman Chemical Co. (Ann Arbor, MI). Primary anti-
bodies for ODC, extracellular signal-regulated protein kinase (ERK)-1/2,
pERK1/2, p38, pp38, c-jun-N-terminal kinase (JNK)-1/2, pJNK1, pJNK2
and p65 were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-IjBa
was from Cell Signaling Technology (Beverly, MA). Anti-rabbit and anti-goat
horseradish peroxidase-conjugated secondary antibodies were products of San-
ta Cruz Biotechnology. An oligonucleotide probe containing the nuclear fac-
tor-jB (NF-jB) consensus sequence from the mouse COX-2 promoter region
was obtained from Bionics (Seoul, Korea). Enhanced chemiluminescence de-
tection kit and [c-32P]ATP were purchased from Amersham Pharmacia Biotech
(Buckinghamshire, UK). Bicinchoninic acid (BCA) protein assay kit was ob-
tained from Pierce (Rockford, IL).
Isolation of xanthorrhizol
Xanthorrhizol was isolated from the rhizomes of C.xanthorrhiza as described
previously (21). Briefly, the dried rhizomes (100 g) of C.xanthorrhiza purchased
from the market in Yokjakarta, Indonesia (voucher specimen no. YS98015)
were extracted with 75% MeOH (v/v, 400 ml). The concentrated methanol
extract was fractioned successively with ethyl acetate, n-butanol and water.
Xanthorrhizol was isolated from the ethyl acetate fraction using silica gel col-
umn chromatography (Merck, Seoul, Korea; 70–230 meshes, 5  43 cm,
n-hexane–ethyl acetate 5 10:1, v/v). Xanthorrhizol was identified by direct
comparison of the 1H-nuclear magnetic resonance (NMR), 13C-NMR and elec-
tron ionization (EI)-mass spectral results with previously published data (28).
Animals
Female ICR mice (5–6 weeks of age) were supplied from the Dae-Han Biolink
Experimental Animal Center (Daejeon, Korea). The animals were fed with
a standard laboratory diet (Daejong, Seoul, Korea) and water ad libitum, and
kept on a 12 h light–dark cycle at a temperature of 22 ± 2C. Animal studies
were performed after the experimental protocols approved by animal ethics
committee of Yonsei University College of Dentistry.
TPA-induced mouse ear edema
The right ear of each female ICR mouse (6 weeks of age, six animals per group)
was topically treated with various concentrations of xanthorrhizol in 50 ll of
vehicle (DMSO–acetone5 15:85, v/v) 30 min prior to the application of 5 nmol
TPA in 50 ll vehicle. The left ears were treated with vehicle alone. The control
group received vehicle only on both ears. Four hours later, the mice were killed
by cervical dislocation and the ears were removed. Right and left ear punches 6
mm in diameter were taken from each mouse. Edema was measured as the
difference between the weight of the right ear punch and that of the left. The
increase in edema was directly proportional to the degree of inflammation.
TPA-induced acute inflammation in mouse skin
Female ICR mice (6 weeks of age, six per group) were topically treated with
various concentrations of xanthorrhizol in 0.2 ml vehicle (DMSO–acetone 5
15:85, v/v) 30 min prior to the application of 10 nmol TPA in 0.2 ml vehicle
on a shaved area of their back. Control mice were treated with vehicle alone.
One (for NF-jB), 2 (for iNOS) and 4 h (for ODC and COX-2) later, the mice
were killed and the excised dorsal skin was immediately placed at 80C until
analysis.
Two-stage mouse skin carcinogenesis
The dorsal region of 6-week-old female ICR mice (30 per group) was shaved
with an electric clipper. To evaluate the antitumor-promoting activity of xan-
thorrhizol, the mice were treated topically with a single dose of 0.2 lmol
DMBA dissolved in 0.2 ml acetone. One week later, the DMBA-initiated mice
were topically treated with 7.5 nmol TPA in 0.2 ml vehicle (DMSO–acetone5
15:85, v/v) three times weekly for 19 weeks. Two and 6 lmol xanthorrhizol in
0.2 ml vehicle was topically applied 30 min before each TPA treatment. Con-
trol mice were pre-treated with vehicle alone.
The inhibitory activity of xanthorrhizol on papillomagenesis was examined
at different stages of tumor promotion. One week after a single topical app-
lication of 0.2 lmol DMBA in 0.2 ml acetone, the mice were treated with
7.5 nmol TPA in 0.2 ml vehicle three times weekly for 6, 18 and 24 weeks to
induce papillomas with hyperplasia, mild dysplasia and moderate dysplasia as
described previously (29). Two weeks later, the mice were topically treated
with 6 lmol xanthorrhizol in 0.2 ml vehicle for 6 weeks. Control mice were
treated with vehicle alone.
Tumors that were at least 1 mm in diameter were counted and recorded
biweekly and the results were expressed as the average number of tumors
per mouse (tumor multiplicity) and as the percentage of tumor-bearing mice
(tumor incidence). After the termination of the experiments, the mice were
killed and the excised dorsal skins were immediately stored at 80C until
analysis.
Protein extraction
For the isolation of protein, the dorsal skins of mice derived from TPA-induced
acute inflammation and the two-stage skin carcinogenesis experiments were
excised. After the fat from the whole skin was removed on ice, the epidermis
was immediately pulverized in liquid nitrogen. The pulverized skin was ho-
mogenized for 1 h in 800 ll of ice-cold lysis buffer [20 mM Tris–HCl (pH 7.5),
150 mM NaCl, 1 mM Na2EDTA, 1 mM ethyleneglycol-bis(aminoethylether)-
tetraacetic acid, 0.5% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-
glycerophosphate, 1 mM Na3VO4 and 1lg/ml leupeptin] containing a protease
inhibitor cocktail tablet (Boehringer-Mannheim, Mannheim, Germany). The
lysate was centrifuged at 14 000 r.p.m. for 30 min at 4C. The supernatant was
collected, aliquoted and used as total protein extracts. The protein concentra-
tion was determined by BCA protein assay.
To prepare cytosolic and nuclear extracts from mouse skin, the fat-free
mouse dorsal skin was homogenized in 1 ml of hypotonic buffer [10 mM N-
2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid (pH 7.9), 2 mM MgCl2,
10 mM KCl, 1 mM dithiothreitol, 0.1 mM ethylenediaminetetraacetic acid
(EDTA) and 0.1 mM phenylmethylsulfonylfluoride]. A volume of 125 ll of
10% Nonidet P-40 solution was added to the homogenates and the mixture
centrifuged at 12 000 r.p.m. for 30 sec. The supernatant was collected as
cytosolic extract. The pelleted nuclei were washed with 400 ll of the above
buffer plus 25 ll of 10% Nonidet P-40, centrifuged and re-suspended in 50 ll
of 20 mM N-2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid (pH 7.9) con-
taining 10% glycerol, 400 mM NaCl, 50 mM KCl, 0.2 mM EDTA, 0.5 mM
dithiothreitol and 0.2 mM phenylmethylsulfonylfluoride. The mixture was in-
cubated on ice for 20 min and centrifuged at 12 000 r.p.m. for 5 min at 4C.
The supernatants were collected and used as nuclear extracts after determina-
tion of protein concentrations.
Western blotting
Whole extract and cytosolic or nuclear extract samples containing 30 lg pro-
tein were boiled in sodium dodesylsulfate sample buffer for 5 min and resolved
on 12% sodium dodesylsulfate–polyacrylamide gels. After electrophoresis, the
proteins in the gel were transferred to polyvinylidene fluoride membranes
(Amersham, Arlington Heights, IL). The blots were blocked with 5% non-
fat dry milk in phosphate-buffered saline containing 0.1% Tween 20 (PBST)
for 2 h at room temperature and then washed in PBST buffer. The membranes
were incubated for 4 h at room temperature with 1:1000 dilutions of the
primary antibodies against ODC, COX-2, IjBa, ERK1/2, pERK1/2, p38 or
pp38, for 2 h with 1:2000 dilutions of the primary antibodies against iNOS or
NF-jB (p65) or for 12 h at 4C with a 1:500 dilution of primary antibodies
against JNK1/2, pJNK1 or JNK2. Blots were washed three times with PBST at
5 min intervals followed by incubation with a 1:5000 dilution of the respective
horseradish peroxidase-conjugated secondary antibodies (rabbit or goat) for
1 h, and again washed three times with PBST. The targeted proteins were
visualized with an enhanced chemiluminescence detection kit according to
the manufacturer’s protocol.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay was performed using a DNA protein-
binding detection kit (Gibco BRL, Grand Island, NY) according to the
manufacturer’s protocol. Briefly, the NF-jB oligonucleotide probe (5#-AGTT-
GAGGGGACTTTCCCAGGC-3#) was labeled with [c-32P]ATP by T4 poly-
nucleotide kinase and purified on a Nick column (Amersham Pharmacia
Biotech). The binding reaction was carried out in a total volume of 25 ll
containing 10 mM Tris–HCl (pH 7.5), 100 mM NaCl, 1 mM dithiothreitol,
1 mM EDTA, 4% (v/v) glycerol, 0.1 mg/ml sonicated salmon sperm DNA,
10 lg nuclear extracts and 100 000 c.p.m. of the labeled probe. After 50 min
incubation at room temperature, samples were separated by electrophoresis on
6% non-denaturing polyacrylamide gels at 150 V in 0.25 Tris–Borate–EDTA
buffer. Finally, the gel was then dried and exposed to X-ray film.
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Statistical analysis
Data were expressed as the mean ± SE of at least three independent experi-
ments. One-way analysis of variance was conducted using SAS software (8.1,
SAS Institute, Cary, NC) to assess the anti-inflammatory activity of xanthor-
rhizol using a mouse ear edema test. Two-way analysis of variance was per-
formed to determine antitumor activity of xanthorrhizol in a two-stage mouse
skin carcinogenesis model. Repeated-measured analysis was used for tumor
multiplicity of each time point. P values , 0.05 were considered to be statis-
tically significant.
Results
Inhibitory effect of xanthorrhizol on TPA-induced acute inflammation
The anti-inflammatory effect of xanthorrhizol was evaluated by de-
termining its inhibitory effect on TPA-induced ear edema in mice. As
shown in Figure 1, ear edema induced by the topical application of
TPA was suppressed by pre-treatment with xanthorrhizol in a dose-
related manner (P , 0.005). Topical application of xanthorrhizol
alone did not induce ear edema in mice.
Inhibitory effect of xanthorrhizol on TPA-induced tumor formation
in mice
To examine the antitumor-promoting activity of xanthorrhizol, we
examined the inhibitory effects of xanthorrhizol on TPA-induced tu-
mor formation in DMBA-initiated mouse skin. All the mice treated
with 7.5 nmol TPA for 19 weeks after initiation by DMBA developed
an average of 15.5 ± 2.3 skin tumors per mouse (tumor multiplicity).
Pre-treatment with 2 and 6 lmol xanthorrhizol reduced tumor multi-
plicity to 6.9 ± 1.1 (P , 0.005) and 4.0 ± 1.1 (P , 0.005), respec-
tively, at 19 weeks. In addition, xanthorrhizol at 2 and 6 lmol dose
dependently lowered the percentage of tumor-bearing mice (tumor
incidence) to 80 and 57%, respectively, at the termination of the
experiments (Figure 2).
Furthermore, the tumor multiplicity (P , 0.05) and incidence
were reduced in the DMBA-initiated mice that were topically treated
with xanthorrhizol for 6 weeks after the induction of papillomas with
hyperplasia, mild dysplasia and moderate dysplasia by topical TPA
application for 6, 18 and 24 weeks, respectively, as summarized in
Table I.
Inhibitory effect of xanthorrhizol on TPA-induced ODC expression in
mouse skin
The ODC protein is a rate-limiting enzyme in the synthesis of poly-
amines that play pivotal roles in cell growth and proliferation, and
induced expression of ODC is recognized as a biochemical hallmark
of tumor promotion (30). The expression of ODC was increased
markedly in mouse epidermis with TPA-induced acute inflammation
(Figure 3A), in mouse epidermis treated with TPA for 19 weeks after
DMBA initiation (Figure 3B) and in mouse epidermis at the different
promotional stages induced by TPA treatment for 6, 18 and 24 weeks,
respectively, after DMBA initiation (Figure 3C). The increased ODC
expression in mouse epidermis with acute inflammation and tumor
promotion induced by TPA was inhibited by pre-treatment with xan-
thorrhizol in a dose-dependent manner (Figure 3A and B). The topical
application of xanthorrhizol after the induction of papillomas with
hyperplasia and dysplasia also potently inhibited ODC expression
(Figure 3C).
Inhibitory effect of xanthorrhizol on TPA-induced COX-2 and iNOS
expression in mouse skin
Previous studies demonstrated transiently increased iNOS and COX-2
protein levels with maximal expression at 2 and 4 h, respectively, after
the topical application of 10 nmol TPA onto shaved areas on the backs
of female ICR mice (31). In the present study, we first confirmed that
iNOS and COX-2 expression was elevated in mouse epidermis treated
with TPA for 2 and 4 h, respectively (Figure 3A), in TPA-promoted
mouse epidermis for 19 weeks after DMBA initiation (Figure 3B), and
in the epidermis of DMBA-initiated mice at the different promotional
stages induced by TPA treatment for 6, 18 and 24 weeks, respectively
(Figure 3C). Pre-treatment with xanthorrhizol 30 min prior to the
topical application of TPA resulted in a dose-dependent decrease in
the level of iNOS and COX-2 protein in mouse skin with TPA-induced
acute inflammation (Figure 3A) as well as in the DMBA-initiated
mouse skin promoted by TPA for 19 weeks (Figure 3B). In addition,
TPA-induced up-regulation of iNOS and COX-2 was significantly
suppressed by xanthorrhizol treatment at the different promotional
stages with hyperplasia, mild dysplasia and moderate dysplasia, re-
spectively (Figure 3C).
Inhibitory effect of xanthorrhizol on TPA-induced NF-jB activation in
mouse skin
Recent studies demonstrated that NF-jB is involved in the regulation
of iNOS and COX-2 expression (32). NF-jB is sequestered in the
cytoplasm by its association with the inhibitory binding protein IjBa.
The phosphorylation, ubiquitination and subsequent degradation of
IjBa release NF-jB and allow it to enter the nucleus where it induces
the expression of iNOS and COX-2. To determine the effect of xan-
thorrhizol on TPA-stimulated NF-jB activation in mouse skin, we
examined the cytosolic level of IjBa and the nuclear translocation
of NF-jB by western blot analysis. The topical application of xan-
thorrhizol 30 min prior to TPA treatment dose dependently inhibited
the TPA-induced degradation of IjBa protein in mouse skin. In ad-
dition, xanthorrhizol treatment caused a significant reduction of TPA-
induced nuclear translocation of p65, the functionally active subunit
of NF-jB protein and TPA-induced DNA binding of NF-jB. Inter-
estingly, xanthorrhizol treatment alone appeared to induce NF-jB
nuclear translocation and DNA binding (Figure 4A). However, xan-
thorrhizol inhibited the TPA-induced activation of NF-jB by blocking
the degradation of IjBa protein in mouse skin pre-treated with xan-
thorrhizol before tumor promotion with TPA (Figure 4B), and also in
mouse skin topically applied by xanthorrhizol for 6 weeks after the
induction of papillomas with hyperplasia and dysplasia (Figure 4C).
Fig. 1. Inhibitory effect of xanthorrhizol on TPA-induced mouse ear edema.
The right ear of each female ICR mouse was topically treated with various
concentrations of xanthorrhizol in 50 ll of vehicle (DMSO–acetone5 15:85,
v/v) 30 min prior to the application of 5 nmol TPA in 50 ll vehicle. The left
ears of each mouse were treated with vehicle alone. The control group
received vehicle only on both ears. Four hours later, the mice were killed by
cervical dislocation and the ears were removed. Right and left ear punches
6 mm in diameter were taken from each mouse. Edema was measured as the
difference between the weight of the right ear punch and that of the left. Data
are expressed as mean ± SE obtained from 6 mice per group. Experiments
were repeated twice independently. Significantly different from the TPA
alone treated group (P , 0.005).
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Inhibitory effect of xanthorrhizol on TPA-induced activation of
mitogen-activated protein kinases and Akt in mouse skin
It has been reported that topical application of TPA in mouse skin
results in a marked increase in the phosphorylated form of ERK, JNK
and p38 kinase (33–35). These mitogen-activated protein kinases
(MAPKs) regulate, at least in part, the induction of COX-2 through
NF-jB activation in mouse skin with TPA-induced inflammation
(33–35). In the present study, western blot analysis showed that the
activation of MAPKs was gradually increased during progression of
TPA-induced papillomagenesis in DMBA-initiated mouse skin. Akt
activation was highly increased in mouse skin with mild dysplasia
rather than in mouse skin with moderate hyperplasia. The phosphor-
ylation of these MAPKs and Akt as well as the expression of JNK, p38
kinase and Akt in mouse skin was significantly suppressed by the
topical application of xanthorrhizol for 6 weeks following the induc-
tion of papillomas with hyperplasia, mild dysplasia and moderate
dysplasia (Figure 5).
Discussion
Carcinogenesis is a multi-step process exemplified by initiation, pro-
motion and progression steps in which genetic and epigenetic events
determine the neoplastic conversion of normal cells (36). Tumor pro-
motion is a reversible event, at least in early stages, and repeated and
prolonged applications of a promoting agent are required to promote
tumorigenesis. Dietary phytochemicals may intervene to alter the
expression or activity of intracellular signaling proteins involved in
the process of tumor promotion and to block or reverse deleterious
changes in cellular signaling, thereby preventing cancer (4).
The mouse skin carcinogenesis model represents one of the best
means to study malignant transformation, including the multi-stage
nature of tumor development and the molecular mechanisms that
contribute to the development of human epithelial cancers. The
DMBA–TPA mouse skin tumorigenesis protocol predominantly gen-
erates an A-T DNA base transversion at codon 61 of the H-ras gene
that results in a constitutively activated Ras protein (37). Thus, acti-
vation of ras is an essential step in tumor initiation. Ras activates
several downstream signal transduction pathways including the
Raf–MAPK Kinase (MAPK) and the phosphatidylinositol 3-kinase–
phosphatase and tensin homologue deleted on chromosome 10
(PTEN)–Akt pathways. These two pathways are highly relevant in
the process of tumor promotion and progression in mouse skin carci-
nogenesis, affecting not only cell proliferation, but also apoptosis by
promoting the survival of the tumor cells (38).
On the other hand, tumor promotion is closely linked to inflamma-
tion and the induction of ODC. ODC, the rate-limiting enzyme in the
biosynthesis of intracellular polyamines, plays an important role in
the regulation of cell proliferation and development of cancer. Induc-
tion of ODC is known to occur in response to TPA treatment in
DMBA-initiated mouse skin, and ODC is constitutively elevated in
the resulting skin tumors (37). Transgenic mice that over-express
ODC in hair follicle keratinocytes were much more sensitive to
DMBA-induced carcinogenesis than littermate controls, and did not
require treatment with a tumor promoter to develop tumors. These
results suggest that ODC over-expression is a sufficient condition for
tumor promotion in this model (39). The proteins iNOS and COX-2
have been reported to be closely associated with cutaneous inflam-
mation, cell proliferation and skin tumor promotion (19). Like other
early-response gene products, iNOS and COX-2 can be rapidly and
transiently induced by pro-inflammatory mediators and mitogenic
stimuli including cytokines, endotoxins, growth factors, oncogenes
and phorbol esters (12,31). Inappropriate up-regulation of iNOS and
COX-2 has frequently been observed in various pre-malignant and
Fig. 2. Inhibitory effect of xanthorrhizol on mouse skin tumor promotion. Female ICR mice received vehicle (DMSO–acetone 5 15:85, v/v) or 2 and 6 lmol
xanthorrhizol 30 min prior to each topical application of 7.5 nmol TPA three times weekly for 19 weeks following DMBA initiation, as described in Materials and
methods. Control animals received vehicle alone and did not produced papillomas. Tumors of at least 1 mm in diameter were counted and recorded biweekly, and
the results were expressed as the average number of tumors per mouse (tumor multiplicity) and the percentage of tumor-bearing mice (tumor incidence).
Table I. Inhibitory effects of xanthorrhizol at different promotional stages of
two-stage mouse skin carcinogenesis
Treatment The average number of
tumors per mouse
(tumor multiplicity)
The percentage of
tumor-bearing mice
(tumor incidence)
DMBA–TPA6wk–Vehicle6wk 6.0 ± 2.1 32
DMBA–TPA6wk–XT6wk 3.8 ± 0.8 23
DMBA–TPA18wk–Vehicle6wk 14.4 ± 3.3 76
DMBA–TPA18wk–XT6wk 11.2 ± 1.0 59
DMBA–TPA24wk–Vehicle6wk 14.4 ± 1.3 80
DMBA–TPA24wk–XT6wk 11.6 ± 1.3 61
One week after a single topical application of 0.2 lmol DMBA in 0.2 ml
acetone, the mice were treated with 7.5 nmol TPA in 0.2 ml vehicle (DMSO–
acetone 5 15:85) three times weekly for 6, 18 and 24 weeks to induce
papillomas with hyperplasia, mild dysplasia and moderate dysplasia,
respectively. Two weeks later, the mice were topically treated with 6 lmol
xanthorrhizol (XT) in 0.2 ml vehicle for 6 weeks. Control mice were treated
with vehicle alone. Tumors of at least 1 mm in diameter were counted and
recorded biweekly, and the results were expressed as the average number of
tumors per mouse (tumor multiplicity) and the percentage of tumor-bearing
mice (tumor incidence). The superscripts indicate the periods of TPA or XT
application on the dorsal skins of mice.
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malignant tissues (9,40). A considerable amount of compelling
evidence suggests that the inhibition of iNOS and COX-2 expression
or activity is important not only for alleviating inflammation, but also
for the prevention of cancer (26,33,41). Therefore, suppressing of
ODC, iNOS and COX-2 induction during carcinogenic progression
is recognized as an important and commonly accepted approach to
effectively inhibit tumor promotion.
The current study was designed to establish the chemopreventive
potential of xanthorrhizol and to provide a comprehensive evaluation
of the molecular mechanisms underlying its activity in TPA-induced
mouse acute inflammation model, and in the DMBA-initiated and
TPA-promoted mouse skin carcinogenesis model. Our data show that
the topical application of xanthorrhizol before TPA treatment signif-
icantly inhibits TPA-induced mouse ear edema and TPA-induced tu-
mor promotion in DMBA-initiated ICR mouse skin. In addition, we
assessed the effect of xanthorrhizol on papillomagenesis at different
stages of tumor promotion. TPA treatment for 6, 18 and 24 weeks
produced papillomas with hyperplasia, mild dysplasia and moderate
dysplasia, not yet any invasive growth, in DMBA-initiated mouse
skin, as shown in our previous study (29). The topical application of
xanthorrhizol, following the generation of papillomas with TPA-in-
duced epithelial hyperplasia, mild dysplasia and moderate dysplasia in
mouse skin, reduced the number of tumors per mouse (tumor multi-
plicity) and the percentage of tumor-bearing mice (tumor incidence)
in DMBA-initiated mice. These results indicate that the repeated ap-
plication of xanthorrhizol not only delays or inhibits tumor formation,
but also reverses the carcinogenic process in pre-malignant tumors.
To explain the molecular mechanisms underlying the anti-inflam-
matory effect of xanthorrhizol and its protective effect on TPA-caused
tumor promotion in DMBA-initiated ICR mouse skin, we examined
the expression of well-known biomarkers of inflammation and tumor
promotion; ODC, iNOS and COX-2. The ODC, iNOS and COX-2
proteins were highly expressed in mouse skin with hyperplasia com-
pared with control mice treated with vehicle alone. The increased
expression of these biomarkers was maintained during the develop-
ment of papillomas with mild dysplasia and moderate dysplasia. Pre-
treatment with xanthorrhizol inhibited the induction of ODC, iNOS
and COX-2 proteins in mouse skin with TPA-induced inflammation,
and in DMBA-initiated mouse skin treated with TPA for 19 weeks.
When applied to the mouse skin after TPA-induced tumor formation,
xanthorrhizol remarkably suppressed the expression of ODC, iNOS
and COX-2.
The significant inhibition of induction of ODC, iNOS and COX-2
by xanthorrhizol led us to investigate the effects of xanthorrhizol on
the signaling molecules that regulate these proteins. Recent studies
demonstrate that ODC is dramatically induced in response to ras
activation in a variety of in vitro models and in the DMBA–TPA-
treated mouse skin model (37,42). These results suggest that ODC
expression is controlled both transcriptionally and translationally by
the Ras effector pathways Raf–MEK–ERK and phosphatidylinositol
3-kinase/Akt (43,44). Pharmacologic inhibition of ERK by specific
MEK1/2 blockers, such as U0126 and PD98059, prevented the in-
duction of ODC (45). In a transgenic mouse line showing induction of
MEK protein and ERK1/2 phosphorylation but no change in Akt-1, an
examination of tumors revealed high levels of ODC protein and ac-
tivity (46). On the other hand, elevated levels of ODC may cooperate
with Raf–ERK via activation of Akt to convert normal keratinocytes
into invasive malignant cells (47). These previous findings suggest
that the induction of ODC is downstream of ERK activation, whereas
the association of Akt with ODC is not clear.
The expression of iNOS and COX-2 appear to be regulated by
NF-jB in cultured cell lines and in mouse skin with TPA-induced
cutaneous inflammation (19,33). The eukaryotic transcription factor
NF-jB plays a central role in general inflammation as well as tumor-
igenesis (19). Rapid phosphorylation of IjBa and its subsequent deg-
radation after cells are exposed to external stimuli such as mitogens,
inflammatory cytokines and reactive oxygen species leads to in-
creased nuclear translocation and DNA binding of NF-jB. NF-jB
induces the transcription of several target genes including COX-2
and iNOS. The transcriptional activity of NF-jB is regulated via an
Fig. 3. Inhibitory effect of xanthorrhizol (XT) on the TPA-induced expression of ODC, COX-2 and iNOS proteins in mouse skin. (A) Female ICR mice
were topically treated with various concentrations of XT in 0.2 ml vehicle (DMSO–acetone5 15:85, v/v) 30 min prior to the application of 10 nmol TPA in 0.2 ml
vehicle. Control mice were treated with vehicle alone. Two hours (for iNOS) or 4 h (for ODC and COX-2) later, the mice were killed. (B) The DMBA-initiated
mice received vehicle (DMSO–acetone 5 15:85, v/v) or 2 and 6 lmol XT 30 min prior to each topical application of 7.5 nmol TPA three times weekly for
19 weeks. (C) The DMBA-initiated mice were treated with 7.5 nmol TPA three times weekly for 6, 18 and 24 weeks to induce papillomas with hyperplasia,
mild dysplasia and moderate dysplasia, respectively. Two weeks later, the mice were topically treated with 6 lmol XT in 0.2 ml vehicle for 6 weeks. Control mice
were treated with vehicle alone. At the termination of each experiment, the mice were killed. Protein expression was measured by western blot analysis. The
western blot shown is representative of results obtained from more than three animals. The superscripts indicate the periods of TPA or XT application on the dorsal
skins of mice.
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elaborate series of intracellular signal transduction events. Studies
show that ERK (33), p38 (34) and Akt (41) are involved in the tran-
scriptional activation of NF-jB in mouse skin with TPA-induced in-
flammation. Moreover, a recent study using ERK1/ mice proved
the importance of ERK activity in the development of mouse skin
papillomas by DMBA and TPA (48). In the present study, xanthor-
rhizol suppressed the nuclear accumulation and DNA binding of
NF-jB by blocking TPA-induced IjBa degradation in mouse skin
with TPA-induced inflammation. Repeated pre-treatment or post-
treatment following the induction of papilloma with xanthorrhizol
also inhibited IjBa degradation in the cytosol and the translocation
of NF-jB into nucleus in DMBA-initiated mouse skin.
Furthermore, we found that ERK, p38 and JNK phosphorylation
and the level of p38 protein were persistently increased with the pro-
gression of mouse skin papillomagenesis. In mouse skin with mild
dysplasia, Akt activation was highly expressed, but was reduced in
mouse skin with moderate dysplasia compared with mild dysplasia.
The expression of JNK was also remarkably elevated in mouse skin
with hyperplasia and dysplasia induced by TPA. These data were in
accordance with a previous report showing that the content of JNK1
and JNK2 isoforms and JNK activity was increased, and that ERK
was preferentially activated in advanced tumor stages in malignant
cell lines derived from the DMBA–TPA-treated mouse skin carcino-
genesis model (36). Topical application of xanthorrhizol following the
induction of papillomas with hyperplasia and dysplasia blocked the
activation of the upstream molecules ERK, p38 and Akt associated
with NF-jB signaling, as well as that of JNK. The JNK is activated
by oncogenic Ras proteins and results in the activation of activated
protein-1 transcription factor (49). Binding sites for activated protein-
1 are present on the COX-2 promoter, as are sites for NF-jB (50).
Thus, JNK may regulate COX-2 expression through activated protein-
1 rather than through NF-jB in our experimental system.
In conclusion, the present study demonstrates that pre-treatment
with xanthorrhizol inhibits TPA-induced acute inflammation in mice
Fig. 4. Inhibitoryeffect of xanthorrhizol (XT) on TPA-induced NF-jB activation in mouse skin. (A) Female ICR mice were topically treated with various concentrations
of XT in 0.2 ml vehicle (DMSO–acetone5 15:85, v/v) 30 min prior to the application of 10 nmol TPA in 0.2 ml vehicle. Control mice were treated with vehicle alone.
The mice were killed 1 h after the TPA treatment. Nuclear and cytosolic extracts were prepared from the mouse skin for western blot analysis. For analysis by the
electrophoretic mobility shift assay, epidermal nuclear extracts were prepared and incubated with radiolabeled oligonucleotides containing the NF-jB consensus
sequence. (B) The DMBA-initiated mice received vehicle (DMSO–acetone5 15:85, v/v) or 2 and 6 lmol XT 30 min prior to each topical application of 7.5 nmol TPA
three times weekly for 19 weeks. (C) The DMBA-initiated mice were treated with 7.5 nmol TPA three times weekly for 6, 18 and 24 weeks. Two weeks later, the mice
were topically treated with 6 lmol XT in 0.2 ml vehicle for 6 weeks. Control mice were treated with vehicle alone. The IjBa level in cytosolic extracts and the p65 level
in nuclear extracts were measured by western blot analysis. The western blot shown is representative of results obtained from more than three animals. The superscripts
indicate the periods of TPA or XT application on the dorsal skins of mice.
Fig. 5. Inhibitory effect of xanthorrhizol (XT) on TPA-induced expression of
MAPKs and Akt in DMBA-initiated mouse skin at different stages of tumor
promotion. One week after a single topical application of 0.2 lmol DMBA,
the mice were treated with 7.5 nmol TPA three times weekly for 6, 18 and 24
weeks to induce papillomas with hyperplasia, mild dysplasia and moderate
dysplasia, respectively. Two weeks later, the mice were topically treated with
6 lmol XT in 0.2 ml vehicle for 6 weeks. Control mice were treated with
vehicle alone. At the termination of each experiment, the mice were killed
and the dorsal skins were excised. Protein expression was measured by
western blot analysis. The western blot shown is representative of results
obtained from more than three animals. The superscripts indicate the periods
of TPA or XT application on the dorsal skins of mice.
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and TPA-induced tumor promotion in DMBA-initiated mice by re-
ducing the protein levels of ODC, iNOS and COX-2, which are reg-
ulated by the NF-jB pathway, MAPKs and/or Akt. Moreover,
xanthorrhizol treatment led to the reduction of existing skin tumors
in mouse skin carcinogenesis induced by DMBA–TPA. These results
suggest that xanthorrhizol is an attractive candidate for a chemopre-
ventive agent. Above all, this is the first investigation of the changes
that occur in biomarkers closely associated with carcinogenesis at
different stages of tumor promotion in animal model.
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